Saturday 17 October 2026
Export IOSP’s income statement to Excel — free account
Innospec Inc.
IOSP Basic Materials Specialty Chemicals
Innospec Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.8 billion, down 3.65% from fiscal 2024. In the quarter to June 2026, revenue grew 11.8%, EPS grew 33.0% and free cash flow fell 63.2%, each against the same quarter a year earlier. Dividend growth for ten consecutive years; insiders bought in the last twelve months.
96.81
0.21
+0.22%
Follow IOSP
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
7 | 5 | 7 | 6 | 7 | 5 | 7 | 7 | 5 | 6 |
P/E ratio |
16.35 | 76.97 | 21.82 | 19.32 | 23.90 | 77.55 | 22.59 | 17.75 | 27.81 | 20.44 |
P/S ratio |
1.07 | 1.49 | 1.56 | 1.31 | 1.50 | 1.87 | 1.67 | 1.02 | 1.32 | 1.89 |
Altman Z-Score |
4.75 | 5.81 | 5.95 | 5.48 | 4.74 | 4.92 | 5.12 | 3.63 | 3.74 | 3.82 |
Altman Z″-Score (non-manufacturers) |
7.54 | 7.29 | 6.74 | 6.51 | 5.92 | 5.60 | 5.58 | 5.06 | 4.74 | 4.84 |
P/FCF ratio |
29.80 | 22.36 | 23.32 | 64.81 | 39.83 | 19.36 | 19.39 | 20.15 | 34.05 | 20.07 |
Beneish M-Score |
(2.46) | (2.93) | (2.54) | (2.29) | (2.28) | (3.00) | (2.52) | (2.42) | (1.89) | (2.47) |
P/Operating CF |
31.01 | 106.77 | 41.93 | 32.74 | 32.36 | 38.29 | 43.36 | 21.59 | 36.20 | 90.15 |
P/B ratio |
1.43 | 2.26 | 2.64 | 2.47 | 2.16 | 2.36 | 2.76 | 1.83 | 2.16 | 2.55 |
Dividend Safety Score |
79 | — | — | — | — | — | — | — | — | — |
Price to Tangible BV |
2.20 | 3.57 | 4.38 | 4.03 | 3.64 | 4.47 | 5.72 | 4.65 | 6.39 | 12.39 |
EV/Sales |
0.92 | 1.34 | 1.46 | 1.24 | 1.42 | 1.80 | 1.68 | 1.08 | 1.42 | 2.08 |
EV/EBITDA |
9.44 | 11.19 | 14.21 | 10.73 | 12.05 | 21.56 | 12.85 | 8.70 | 10.55 | 13.48 |
EV/Operating CF |
11.81 | 13.42 | 13.77 | 29.88 | 22.60 | 14.70 | 15.70 | 15.19 | 22.38 | 17.42 |
EV/FCF |
25.56 | 20.18 | 21.92 | 61.64 | 37.68 | 18.64 | 19.43 | 21.30 | 36.65 | 22.11 |
Quick Ratio |
1.76 | 1.70 | 1.52 | 1.19 | 1.27 | 1.29 | 1.21 | 1.36 | 1.28 | 1.40 |
Current Ratio |
2.79 | 2.58 | 2.38 | 2.15 | 2.16 | 2.24 | 2.08 | 2.24 | 2.15 | 2.41 |
Net Debt/EBITDA |
(1.69) | (1.31) | (1.01) | (0.65) | (0.81) | (1.06) | (0.08) | 0.47 | 0.75 | 1.25 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.01% | 4.02% | 14.19% | 15.71% | 23.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.06 | 0.25 | 0.28 | 0.42 |
Asset Turnover |
1.00 | 1.07 | 1.18 | 1.24 | 1.00 | 0.83 | 1.03 | 1.02 | 1.01 | 0.80 |
Operating CF/Net income |
1.19 | 5.18 | 1.49 | 0.61 | 1.00 | 5.08 | 1.44 | 1.23 | 1.34 | 1.30 |
Capex/Depreciation |
(1.71) | (1.42) | (1.96) | (1.05) | (0.85) | (0.45) | (0.65) | (0.61) | (0.64) | (0.43) |
Interest Coverage |
— | — | (70.26) | 170.27 | 88.07 | 18.72 | 31.23 | 19.35 | 15.24 | 30.69 |
| 9.15% | 3.01% | 12.70% | 12.83% | 9.41% | 3.08% | 12.86% | 10.50% | 8.54% | 12.91% | |
| 6.54% | 2.07% | 8.40% | 8.38% | 6.27% | 2.00% | 7.63% | 5.90% | 4.77% | 7.36% | |
ROIC |
7.78% | 12.00% | 10.68% | 13.10% | 9.26% | 2.51% | 10.38% | 9.15% | 8.44% | 7.45% |
Return on Tangible Assets |
12.53% | 4.16% | 17.78% | 19.34% | 15.37% | 5.47% | 21.35% | 15.08% | 12.46% | 19.57% |
Average Days of Receivables |
70.27 | 67.58 | 67.39 | 62.19 | 70.00 | 67.73 | 70.43 | 69.12 | 68.29 | 63.79 |
Research and Development Expense of Revenue |
2.87% | 3.06% | 2.51% | 1.97% | 2.52% | 2.59% | 2.34% | 2.26% | 2.40% | 2.88% |
Selling, General and Administrative Expense of Revenue |
16.03% | 16.54% | 19.52% | 18.37% | 18.01% | 19.86% | 18.56% | 17.67% | 18.69% | 24.53% |
Intangible Assets out of Total Assets |
0.25 | 0.26 | 0.27 | 0.25 | 0.27 | 0.32 | 0.32 | 0.34 | 0.37 | 0.44 |
Share Based Compensation of Revenue |
0.46% | 0.46% | 0.41% | 0.34% | 0.30% | 0.49% | 0.44% | 0.33% | 0.31% | 0.37% |
Graham Net Nets |
0.27 | 0.16 | 0.11 | 0.12 | 0.09 | 0.05 | 0.03 | 0.01 | (0.03) | (0.05) |
Graham Number |
75.11 | 39.62 | 76.35 | 71.15 | 59.70 | 31.82 | 62.19 | 51.47 | 43.53 | 45.65 |
Earnings Yield |
6.11% | 1.30% | 4.58% | 5.18% | 4.18% | 1.29% | 4.43% | 5.63% | 3.60% | 4.89% |
Free Cash Flow Yield |
3.36% | 4.47% | 4.29% | 1.54% | 2.51% | 5.16% | 5.16% | 4.96% | 2.94% | 4.98% |
Revenue per Share |
71.46 | 74.02 | 78.42 | 79.22 | 60.19 | 48.57 | 61.81 | 60.53 | 54.12 | 36.81 |
Operating CF per Share |
5.56 | 7.40 | 8.34 | 3.30 | 3.78 | 5.94 | 6.60 | 4.30 | 3.42 | 4.40 |
Capex per Share |
(2.99) | (2.48) | (3.10) | (1.70) | (1.47) | (1.21) | (1.27) | (1.23) | (1.33) | (0.69) |
Free Cash Flow per Share |
2.57 | 4.92 | 5.24 | 1.60 | 2.31 | 4.73 | 5.33 | 3.07 | 2.09 | 3.71 |
Cash per Share |
11.76 | 11.60 | 8.20 | 5.93 | 5.75 | 4.29 | 3.09 | 5.04 | 3.74 | 4.25 |
Shareholders Equity per Share |
53.57 | 48.78 | 46.26 | 41.97 | 41.91 | 38.47 | 37.53 | 33.83 | 32.89 | 27.24 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
53.57 | 48.78 | 46.26 | 41.97 | 41.91 | 38.47 | 37.53 | 33.83 | 32.89 | 27.24 |
Free Cash Flow |
63.90 | 122.70 | 130.20 | 39.60 | 57.00 | 116.20 | 130.60 | 74.80 | 50.50 | 89.00 |
Working Capital |
644.50 | 585.20 | 514.20 | 466.80 | 391.50 | 313.80 | 326.80 | 367.30 | 300.00 | 258.00 |
Capital Expenditures |
(74.40) | (61.80) | (77.10) | (42.10) | (36.20) | (29.70) | (31.00) | (30.10) | (32.20) | (16.50) |
Net Current Asset Value |
505.10 | 438.00 | 327.90 | 309.30 | 190.20 | 113.70 | 80.40 | 16.00 | (54.40) | (86.50) |
EV/EBIT |
12.61 | 13.92 | 17.66 | 13.03 | 15.95 | 63.65 | 16.93 | 11.93 | 14.81 | 18.71 |
Capex to Sales |
0.04 | 0.03 | 0.04 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
Price to Operating Income |
14.71 | 15.42 | 18.79 | 13.70 | 16.86 | 66.13 | 16.89 | 11.29 | 13.75 | 16.98 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.15 | 0.16 | 0.15 | 0.18 | 0.20 | 0.31 | 0.24 | 0.25 | 0.26 | 0.24 |
Cash ROIC |
3.93% | 8.15% | 9.62% | 3.33% | 4.85% | 11.06% | 12.39% | 6.46% | 4.57% | 8.66% |
Accounts Receivable Turnover |
5.20 | 5.26 | 5.61 | 6.34 | 5.86 | 4.65 | 5.29 | 5.63 | 6.55 | 6.05 |
Accounts Payable Turnover |
7.60 | 7.96 | 8.26 | 8.77 | 8.48 | 7.71 | 8.42 | 8.52 | 10.18 | 9.86 |
Inventory Turnover |
4.08 | 4.33 | 4.03 | 4.23 | 4.21 | 3.66 | 4.25 | 4.55 | 4.71 | 3.30 |
Average Days of Payables |
49.60 | 45.90 | 43.98 | 43.82 | 51.76 | 42.36 | 42.53 | 44.42 | 47.63 | 39.47 |
Days of Inventory on Hand |
93.49 | 84.35 | 80.68 | 98.90 | 96.64 | 94.43 | 85.26 | 86.88 | 84.76 | 115.11 |
Average Receivables |
342.00 | 350.75 | 347.20 | 309.55 | 252.95 | 256.70 | 285.85 | 262.10 | 199.45 | 145.90 |
Average Payables |
169.25 | 163.70 | 164.45 | 157.00 | 123.70 | 110.35 | 124.40 | 122.35 | 88.75 | 55.90 |
Average Inventory |
315.15 | 300.55 | 336.60 | 325.35 | 248.80 | 232.30 | 246.30 | 228.90 | 191.80 | 166.85 |
Average Assets |
1,783.55 | 1,721.05 | 1,655.55 | 1,587.30 | 1,484.15 | 1,433.10 | 1,471.10 | 1,441.80 | 1,295.80 | 1,105.00 |
Average Common Equity |
1,274.50 | 1,182.85 | 1,095.00 | 1,036.70 | 988.95 | 931.90 | 872.20 | 809.90 | 724.05 | 629.55 |
Columns are period end dates